INS and obesity due to melanocortin 4 receptor deficiency: The high prevalence of obesity, together with its accompanying diseases, has led to increased interest in research on improving insulin sensitivity and inhibiting adipogenesis (Hurt et al., 2010; Raciti et al., 2018; Willis et al., 2021).